Clinical Trial Update: Paclitaxel (Albumin-bound) Combined With Radiotherapy for the Treatment of Early Stage Nasopharyngeal Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating paclitaxel albumin-bound with radiotherapy for early-stage nasopharyngeal carcinoma is ongoing but results are not yet available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Paclitaxel (albumin-bound) (paclitaxel albumin-bound)

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Nasopharyngeal Carcinoma | Phase 3 | Status: UNKNOWN